Repository logo
 

ESCRT-III-associated proteins and spastin inhibit protrudin-dependent polarised membrane traffic.

Published version
Peer-reviewed

Change log

Abstract

Mutations in the gene encoding the microtubule severing ATPase spastin are the most frequent cause of hereditary spastic paraplegia, a genetic condition characterised by length-dependent axonal degeneration. Here, we show that HeLa cells lacking spastin and embryonic fibroblasts from a spastin knock-in mouse model become highly polarised and develop cellular protrusions. In HeLa cells, this phenotype was rescued by wild-type spastin, but not by forms unable to sever microtubules or interact with endosomal ESCRT-III proteins. Cells lacking the spastin-interacting ESCRT-III-associated proteins IST1 or CHMP1B also developed protrusions. The protrusion phenotype required protrudin, a RAB-interacting protein that interacts with spastin and localises to ER-endosome contact sites, where it promotes KIF5-dependent endosomal motility to protrusions. Consistent with this, the protrusion phenotype in cells lacking spastin also required KIF5. Lack or mutation of spastin resulted in functional consequences for receptor traffic of a pathway implicated in HSP, as Bone Morphogenetic Protein receptor distribution became polarised. Our results, therefore, identify a novel role for ESCRT-III proteins and spastin in regulating polarised membrane traffic.

Description

Journal Title

Cell Mol Life Sci

Conference Name

Journal ISSN

1420-682X
1420-9071

Volume Title

77

Publisher

Springer Science and Business Media LLC

Rights and licensing

Except where otherwised noted, this item's license is described as Attribution 4.0 International (CC BY 4.0)
Sponsorship
Wellcome Trust (082381/Z/07/Z)
Medical Research Council (MR/M00046X/1)
Medical Research Council (MR/R026440/1)
MRC (1366897)
Wellcome Trust (100140/Z/12/Z)
Wellcome Trust (093026/Z/10/Z)
MRC (MR/K50127X/1)
This work was supported by grants to ER; UK Medical Research Council Project Grants [MR/M00046X/1] and [MR/R026440/1], Project grant from National Institute for Health Research Biomedical Research Centre at Addenbrooke’s Hospital, Wellcome Trust Senior Research Fellowship in Clinical Science [082381]. GJP and EZ were supported by Medical Research Council PhD studentship [MR/K50127X/1]. EZ was supported by a Gates Cambridge Trust Scholarship. CIMR was supported by a Wellcome Trust Strategic Award [100140] and Equipment Grant [093026].